BIOC Market Cap History
Below is a table of the BIOC market cap history going back to 9/29/2016:

Date BIOC Market Cap
9/29/201613.77M
11/4/201612.95M
3/24/201749.68M
5/9/201748.15M
8/10/201743.87M
11/9/201728.14M
3/26/201821.09M
4/24/201816.33M
5/11/201815.01M
7/10/20188.37M
8/10/20189.14M
11/7/20188.16M
3/25/201919.38M
5/10/201917.17M
8/10/201923.48M
11/8/201915.19M
3/20/202029.35M
5/8/202053.75M
8/7/2020135.27M
9/8/202059.20M
11/6/202059.62M
3/19/202178.40M
5/7/202161.79M
8/12/202161.39M

Also see: BIOC Shares Outstanding History
and BIOC YTD Return
BIOC Historical Market Cap:
+35.92% CAGR
BIOC Historical Market Cap: +35.92% CAGR

Mouse over chart for data details
9/29/2016 ...8/12/2021
Biocept is an early stage molecular oncology diagnostics company that develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample. Co.'s assays are intended to provide information to aid healthcare providers to identify specific oncogenic alterations that may qualify a subset of cancer patients for targeted therapy at diagnosis, show progression or be used for monitoring in order to identify specific resistance mechanisms. Co. has commercialized its Target-Selector™ assays for a number of solid tumor indications such as: breast cancer, non-small cell lung cancer, gastric cancer, prostate cancer, and ovarian cancer. We show 24 historical shares outstanding datapoints in our BIOC shares outstanding history coverage, used to compute BIOC market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BIOC market cap history over the course of time is important for investors interested in comparing BIOC's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BIOC versus a peer is one thing; comparing BIOC market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BIOC can fluctuate over the course of history. With this page we aim to empower investors researching BIOC by allowing them to research the BIOC market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree BIOC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Biocept (BIOC) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

BIOL Market Cap History
BIOS Market Cap History
BIVI Market Cap History
BKD Market Cap History
BLCM Market Cap History
BLFS Market Cap History
BLI Market Cap History
BLPH Market Cap History
BLRX Market Cap History
BLUE Market Cap History
More Healthcare companies »

 

BIOC Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.